DexCom (DXCM) Revenue — Quarter Ended Mar 31, 2023
Revenue declined sequentially from the prior quarter but increased compared to the same quarter last year. The trailing twelve-month revenue remained at a multi-quarter high level.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q1
Revenue declined sequentially from the prior quarter but increased compared to the same quarter last year. The trailing twelve-month revenue remained at a multi-quarter high level.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$741.5M
Revenue reported for this quarter.
Quarter-over-quarter
-9.0%
Change from the immediately preceding quarter.
Year-over-year
+17.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $696.2M | +17.0% |
| Sep 30, 2022 | $769.6M | +18.4% |
| Dec 31, 2022 | $815.2M | +16.8% |
| Mar 31, 2023 | $741.5M | +17.9% |
Revenue performance
Reported revenue moved lower from the immediately preceding quarter, reflecting a sequential contraction after several quarters of growth.
Quarterly comparison
Compared with the same quarter one year earlier, revenue was higher, maintaining a year-over-year expansion. The sequential decline contrasts with the upward trend seen in the prior three quarters.
What to watch
The sequential revenue reversal warrants attention given the prior multi-quarter growth pattern.